|
|
 |
|
Viewing report
|
|
|
|
Clinical Trials in Oncology
Arena-International, Nov 2010
The proceedings from VIB Pharma's 2010 Clinical Trials in Oncology conference
VIBpharma delivered cutting edge conference content for professionals in pharmaceutical and biotech companies concerned with clinical trials in oncology. Now you can secure the latest information in this space without venturing outside your office.
This package includes audio and presentation materials from the keynote speeches, industry-leading case studies and insightful Q&A sessions; ensuring you and your colleagues remain at the forefront of this rapidly developing industry.
Scope:
- Expediting and strengthening Phases I-III through innovative and effective proven methods of improving suitability of trial setup
- Optimising candidate and investigator engagement and patient recruitment within varying European guidelines
- Exploiting opportunities, possibilities and rewards of biomarker-led drug development
- Achieving optimal trial development through full understanding of regulation, exploitation of regulatory advisory services and tips on time-effective application and submission
Reasons to buy:
- Take away applicable, implementable strategies relevant to your ongoing and future trials and development plans from successful case studies
- Exploit new opportunities in targeted therapies whilst mitigating risks
- Learn directly from the leaders and implementers of cutting edge biomarker and adaptive projects
- Explore what works and what doesn’t in oncology drug development in Europe and further afield, through the lessons learned by operational experts, project leaders, and regulatory authorities in clinical trials in oncology
- Select the most suitable primary endpoint to ensure positive implications for cost control, funding, licensing and reimbursement
|
|
|
|
